Low-dose thalidomide in myelofibrosis

Haematologica

Volumn 93, Issue 7, 2008, Pages 1100-1101

  Weinkove, Robert ^a   Reilly, John T ^b   McMullin, Mary Frances ^c   Curtin, Natasha J ^d   Radia, Deepti ^a   Harrison, Claire N ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

^b ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

^c BELFAST CITY HOSPITAL   (United Kingdom)

^d QUEEN ELIZABETH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PREDNISOLONE; THALIDOMIDE;

BLOOD TRANSFUSION; CLINICAL ARTICLE; CONSTIPATION; DRUG RESPONSE; FOLLICULITIS; GENE MUTATION; GLIOBLASTOMA; HUMAN; LETTER; LEUKOCYTOSIS; MYELOFIBROSIS; NEUROPATHY; PERIPHERAL NEUROPATHY; PNEUMONIA; SIDE EFFECT; SPLENOMEGALY; THROMBOCYTE COUNT; WEIGHT GAIN;

AGED; AGED, 80 AND OVER; BLOOD TRANSFUSION; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; MYELOFIBROSIS; PREDNISOLONE; SPLEEN; STEM CELL TRANSPLANTATION; THALIDOMIDE; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 46849115142     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: 10.3324/haematol.12416     Document Type: Letter

References (9)

1. Cervantes F. Modern management of myelofibrosis Br J Haematol 2005;128:583-92.
2. Mesa RA, Hanson CA, Rajkumar SV, Schroeder G, Tefferi A. Evaluation and clinical correlations of bone marrow angiogenesis in myelofibrosis with myeloid metaplasia. Blood 2000;96:3374-80.
3. Elliott MA, Mesa RA, Li CY, Hook CC, Ansell SM, Levitt RM, et al. Thalidomide treatment in myelofibrosis with myeloid metaplasia. Br J Haematol 2002;117:288-96.
4. Mesa RA, Steensma DP, Pardanani A, Li CY, Elliott M, Kaufmann SH, et al. A phase 2 trial of combination low-dose thalidomide and prednisone for the treatment of myelofibrosis with myeloid metaplasia. Blood 2003; 101: 2534-41.
5. Marchetti M, Barosi G, Balestri F, Viarengo G, Gentili S, Barulli S, et al. Low-dose thalidomide ameliorates cytopenias and splenomegaly in myelofibrosis with myeloid metaplasia: a phase II trial J Clin Oncol 2004;22:424-31.
6. Barosi G, Ambrosetti A, Finelli C, Grossi A, Leoni P, Liberato NL, et al. The Italian Consensus Conference on Diagnostic Criteria for Myelofibrosis with Myeloid Metaplasia. Br J Haematol 1999;104:730-7.
7. Barosi G, Bordessoule D, Briere J, Cervantes F, Demory JL, Dupriez B, et al. Response criteria for myelofibrosis with myeloid metaplasia: results of an initiative of the European Myelofibrosis Network (EUMNET). Blood 2005;106: 2849-53.
8. Tefferi A, Barosi G, Mesa RA, Cervantes F, Deeg HJ, Reilly JT, et al. International Working Group (IWG) consensus criteria for treatment response in myelofibrosis with myeloid metaplasia, for the IWG for Myelofibrosis Research and Treatment (IWG-MRT). Blood 2006;108: 1497-503.
9. Jack FR, Smith SR, Saunders PW. Idiopathic myelofibrosis: anaemia may respond to low-dose dexamethasone. Br J Haematol 1994;87:877-8.